An article by our contributor Irene Tarragó

Based on the fact that I speak from my own experience and that each case is unique, I can say that, in most cases, yes.

Having this disease, women have doubts about becoming pregnant. Is epilepsy hereditary? Do I have to stop taking medication during my pregnancy?

All these doubts should be asked to our neurologist and our gynaecologist. They are professionals and the only ones who can answer our questions. When it comes to stopping the medication, of course NEVER on your own initiative. Always follow the specialist’s instructions. And, if epilepsy is hereditary, the answer is no, it is not. It happens as with other diseases that create a certain predisposition to have it, but it is not hereditary.

I personally had two children. I’m talking about 35 years ago (my oldest son is 34 and my youngest is 29). It is curious that each pregnancy was carried out by a different gynaecologist and the two of them coincided in making me have a caesarean section. They didn’t want to expose me to the effort of childbirth. But it doesn’t always have to be like this. I have met women with epilepsy who have given birth normally. My children were born healthy. In the next blog post, I will tell you what happened to one of them and how I handled it.

MJN-SERAS
Find out your risk of having an epilepsy crisis at any time and place.

Leave a Reply

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.